SCHEMBL6673635

SCHEMBL6673635

CCOC(=O)C1=C(O)CCc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.56
ALDH1A1 P00352 8/20 0.56
KDM4E B2RXH2 6/20 0.56
TDP1 Q9NUW8 4/20 0.56
L3MBTL1 Q9Y468 3/20 0.56
SMN1; SMN2 Q16637 5/20 0.51
MAPT P10636 8/20 0.47
KMT2A Q03164 7/20 0.47
MEN1 O00255 6/20 0.47
LMNA P02545 5/20 0.47
NPSR1 Q6W5P4 5/20 0.47
ALOX12 P18054 4/20 0.47
PKM P14618 2/20 0.47
HTT P42858 2/20 0.47
STAT3 P40763 1/20 0.47
KCNH2 Q12809 1/20 0.47
CARM1 Q86X55 1/20 0.46
TSHR P16473 2/20 0.46
CCR6 P51684 3/20 0.45
HKDC1 Q2TB90 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4971253 0.91 HPGD (0.50) HPGDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL6654078 0.83 ALDH1A1 (0.52) HPGDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL26080869 0.82 ALDH1A1 (0.53) HPGDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL7500172 0.82 ALDH1A1 (0.44) HPGDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL6687365 0.81 CYP3A4 (0.50) HPGDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL6648388 0.80 ALDH1A1 (0.42) HPGDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL21855441 0.80 CDC7 (0.42) HPGDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL6653339 0.80 SRD5A1 (0.44) HPGDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL9378392 0.77 MAPT (0.46) HPGDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL13790503 0.76 ALDH1A1 (0.51) HPGDALDH1A1KDM4ETDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762188-B1 INHIBITING THYMIDYLATE SYNTHASE; COLON, BREAST OR LUNG CARCINOMA SMITHKLINE BEECHAM CORPORATION 2004-07-13 US disclosed
EP-1199307-B1 Pharmaceutically active benzoquinazoline compounds WELLCOME FOUND (GB) 2004-02-25 EP disclosed
EP-0535034-B1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS WELLCOME FOUND (GB) 2002-08-14 EP disclosed
EP-1199307-A1 Pharmaceutically active benzoquinazoline compounds THE WELLCOME FOUNDATION LIMITED (GB) 2002-04-24 EP disclosed
US-6306865-B1 SYNTHASE INHIBITORS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. 2001-10-23 US disclosed
US-6090941-A Pharmaceutically active benzoquinazoline compounds GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
US-5663337-A ENZYME, ANTITUMOR GLAXO WELLCOME INC. (US) 1997-09-02 US disclosed
US-5661155-A THYMIDYLATE SYNTHASE INHIBITOR; ADMINISTERING TO THE MAMMAL SUFFERING FROM LEUKEMIA OR TUMOR 2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLINE-9-YL) METHYL)AMINO)-1-OXO-2-ISOINDOLINYL)GLUTARIC ACID OR SALTS GLAXO WELLCOME INC. (US) 1997-08-26 US disclosed
US-5405851-A Administering benzoquinazoline thymidylate synthase inhibitors BURROUGHS WELLCOME CO. (US) 1995-04-11 US disclosed
EP-0535034-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1993-04-07 EP disclosed
WO-1991019700-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-26 WO disclosed